HomeBiotechnologyCatalent Opens Industrial-Scale Cell Remedy Manufacturing Facility

Catalent Opens Industrial-Scale Cell Remedy Manufacturing Facility

Catalent reported that it has accomplished and opened a brand new commercial-scale cell remedy manufacturing facility at its European middle of excellence for cell therapies, in Gosselies, Belgium. The brand new facility encompasses 60,000 ft2 (5,600 m2) of devoted cell remedy manufacturing house housing multi-product, segregated suites designed to assist autologous and allogeneic cell remedy manufacturing by means of to late-stage medical and commercial-scale provide.

The power, which has been designed to be EMEA and FDA compliant, with Grade B and C suites to assist high-throughput processes and accommodate bioreactor-scale cell remedy manufacturing in addition to on-site high quality management (QC) laboratories and warehousing, is the newest addition to Catalent’s Gosselies campus, which already features a 67,000 ft2 (6,200 m2 ) medical manufacturing facility providing superior medical and industrial provide options.

The general Gosselies campus supplies course of and analytical growth labs, greater than 20 CGMP grade B and C cleanrooms, devoted QC labs, certified particular person (QP) companies, and warehousing, in line with Manja Boerman, Catalent’s president, BioModalities (Cell, Gene, and Protein Therapies).

“Catalent allows absolutely built-in cell remedy companies—from our iPSC experience in Düsseldorf, Germany, to course of and analytical growth in Gosselies, to medical and industrial manufacturing in Gosselies and Princeton, New Jersey—all beneath one CGMP umbrella,” added Boerman. “Along with our built-in plasmid DNA and viral vector companies, the Catalent Cell & Gene Remedy community supplies end-to-end companies for growth, scaleup, and industrial launch of superior therapies.”

The Gosselies campus additionally contains separate plasmid DNA (pDNA) growth and manufacturing services. The clinical-scale pDNA facility, at 17,000 ft2 (1,600 m2), contains R&D, course of growth, QC labs, and a number of CGMP manufacturing suites. The commercial-scale pDNA facility, at 32,400 ft2  (3,010 m2), affords large-scale manufacturing.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments